Google+

June 15-18, 2015 | Philadelphia, PA

BIO Buzz - Official Show Daily, Brought to you by Alexandria

Business Development/Finance

Videos

Mitch Horowitz, Battelle at the 2014 BIO International Convention
Jeff Hatfield, Vitae Pharmaceuticals at the 2014 BIO International Convention
Welcome to BIO 2014!
Kim Guadagno, Lieutenant Governor, New Jersey at the 2014 BIO International Convention
Ross Sibucao, Hawaii Papaya Industry Association at the 2014 BIO International Convention
Samuel Werthheimer, Poliwogg Healthcare Investments at the 2014 BIO International Convention
Joni Kamiya, Kamiya Papaya at the 2014 BIO International Convention
Rachel King, GlycoMimetics at the 2014 BIO International Convention
BIO President & CEO, Jim Greenwood at the 2014 BIO International Convention
Shaun Grady, AstraZeneca at the 2014 BIO International Convention
Glen Giovannetti, EY at the 2014 BIO International Convention
Sachin Shah, Phasiq Inc. at the 2014 BIO International Convention
Charles Crain, BIO at the 2014 BIO International Convention
Bob Coughlin, MassBio at the 2014 BIO International Convention
BIO 2014 Partnering Highlights

Articles from BioTechNow

Why We Do This Work

Publish Date: 6/26/2014, Created By: BIOtechNOW Editor


In her keynote remarks delivered yesterday at the 2014 BIO International Convention, Rachel King, president & CEO of GlycoMimetics and chairperson of the board of the Biotechnology Industry Organization (BIO), talked about why entrepreneurs pursue opportunities in biotechnology and what sustains these industry leaders through the rollercoaster of raising money, clinical trials, road shows and all the ups and downs of bringing medical innovations from the lab to the bedside. “Working in biotechnology today, we ...

Read More >

Wanted: Tax Policies to Support Innovation

Publish Date: 6/25/2014, Created By: BIOtechNOW Editor


Innovative small businesses work to advance research, development, and manufacturing of technologies to help solve economic, environmental, and societal challenges. The Coalition of Small Business Innovators is a national, non-partisan coalition of organizations dedicated to stimulating sustained, private investment in small companies focusing on the development of transformative, life-changing new technologies. Small business innovators are working every day to solve the greatest challenges facing our society – whether it’s finding a cure for cancer, developing ...

Read More >

De-Mystifying Trade Agreements

Publish Date: 6/25/2014, Created By: BIOtechNOW Editor


To many people in our industry, international trade agreements may seem like esoteric documents that have little relevance to the day-to-day workings of a research-based, innovative enterprise. After all, aren’t these agreements more about the cross-border trade of big-ticket goods like autos and wheat than they are about new, cutting edge technologies? Well, actually no. Those who have been paying close attention know that these agreements define many of the underlying rules of the road ...

Read More >

Principles on Clinical Trial Data Sharing Reaffirm Commitment

Publish Date: 6/25/2014, Created By: BIOtechNOW Editor


BIO member companies will honor, at minimum, the following commitments: REGISTERING CLINICAL TRIALS: BIO member companies will register all company-sponsored clinical trials conducted in patients in an appropriate public registry, such as ClinicalTrials.gov or the European Clinical Trials Database (EudraCT). SUMMARIZING THE RESULTS OF CLINICAL TRIALS: BIO member companies will post technical summary results in a clinical trials database as follows: For approved products, all company sponsored clinical trials testing both safety and efficacy in ...

Read More >

Therapeutic Licensing and M&A Deals

Publish Date: 6/24/2014, Created By: David Thomas, CFA


Licensing deals for therapeutic candidates in 2013 dropped to the lowest volume in at least eight years for deals with disclosed values totaling over $10M. Total upfront payments to biotechs were also at an eight year low, with only $1.9B paid to biotechs in 2013. This is a 50 percent drop from peak levels. However, there is a silver lining in the data: Preclinical deal volume saw a slight increase in 2013, and has not ...

Read More >

Biofuel by California

Publish Date: 6/24/2014, Created By: BIOtechNOW Editor


A look at some of the Golden State biotechnology companies that are contributing to the development of biofuels and renewable chemicals CELLANA Cellana uses the most productive plants on earth—marine microalgae—to develop bioproducts. Algae photosynthetically produce a line of Omega-3 EPA and DHA oils, animal feed, and biofuel feedstocks. Cellana’s patented system of serial photobioreactors coupled with open ponds, enables low-cost, continuous production of diverse strains of microalgae. Since 2009, Cellana has operated a 6-acre, ...

Read More >

Bio-fueling the Navy

Publish Date: 6/24/2014, Created By: BIOtechNOW Editor


The research component is anchored by the renowned biotech programs at University of California San Diego (UCSD), the Salk Institute and Scripps Research, which make San Diego a hotbed of biotech innovation. These institutions concentrate biologists, biotech scientists, engineers, and specialists, who in turn attract the entrepreneurs that help convert the research into products and companies. However, it also takes real marketplace demand—often led by a few significant “early adopters”—to put a new technology to ...

Read More >

The Journey from the Bench to Bedside

Publish Date: 6/24/2014, Created By: BIOtechNOW Editor


A partnership between a leading academic research center and a biologics company is aiming to develop new therapeutic opportunities Translational research enables therapies get to where they need to be – to the patient. The process is characterized by collaborative activity between university and company scientists. One recent example is the announcement of a three-year collaboration between MedImmune, the global biologics research and development arm of AstraZeneca, and the Clinical and Translational Science Institute (CTSI) ...

Read More >

New Type of Prospective Survey Initiative

Publish Date: 6/24/2014, Created By: BIOtechNOW Editor


Our industry is on the cutting-edge of science aimed at developing new therapies for devastating and life-threatening diseases. To help advance innovation and promote the development of the next generation of treatments and cures, we must acknowledge that the scientific method does not operate in a vacuum. Robust, interactive FDA-Sponsor communication is a key element of modern drug development. However, in order to improve the drug development enterprise and the FDA review process further, the ...

Read More >

Acts of Support

Publish Date: 6/24/2014, Created By: BIOtechNOW Editor


Because small biotechnology companies do not have product revenue, burdensome regulations have an outsized effect on them. One-size-fits-all compliance requirements – such as Section 404(b) of the Sarbanes-Oxley Act (SOX) – divert funds from the lab and slow the development process. We have already seen the benefits that positive legislative reform can have for capital formation for emerging growth companies (EGCs). The JOBS Act has led to a sea change in the regulatory landscape and ...

Read More >

Thank you to our 2014 Sponsors

Double Helix Sponsors

Helix Sponsors

Sponsors